- Home
- SKIN vs LNSR Comparison
SKIN vs LNSR Comparison
Compare SKIN & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKIN | LNSR |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.9M | 146.7M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SKIN | LNSR |
|---|---|---|
| Price | $0.88 | $5.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $2.03 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 571.9K | 111.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.56 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $300,790,000.00 | $58,435,000.00 |
| Revenue This Year | $0.98 | $10.06 |
| Revenue Next Year | $4.60 | $41.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $0.76 | $5.33 |
| 52 Week High | $2.69 | $14.26 |
Technical Indicators
Market Signals| Indicator | SKIN | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 41.40 | 31.22 |
| Support Level | $0.87 | $5.34 |
| Resistance Level | $1.22 | $6.50 |
| Average True Range (ATR) | 0.07 | 0.35 |
| MACD | 0.01 | 0.21 |
| Stochastic Oscillator | 52.84 | 14.53 |
Price Performance
Historical ComparisonAbout SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.